Resultaten visas 1 - 10 / 27
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer

Referentgranskad
Öppen tillgång
DOI
10.1016/j.ctarc.2022.100517
Falk, Philip; Severin, Mira; Berglund, Åke; Guren, Marianne G.; Hofsli, Eva; Österlund, Pia; Tandber...
Cancer treatment and research communications2022Publicationer information ikon

Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy

Referentgranskad
DOI
10.1080/0284186X.2018.1556804
Soveri, L.M.;Lamminmäki, A.;Hänninen, U.A.;Karhunen, M.;Bono, P.;Österlund, P.Österlund, P.
Acta oncologica2019Publicationer information ikon

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Referentgranskad
Öppen tillgång
Narvi E; Vaparanta K; Karrila A; Chakroborty D; Knuutila S; Pulliainen A; Sundvall M; Elenius K
Scientific Reports2018Publicationer information ikon

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Referentgranskad
Öppen tillgång
DOI
10.1038/s41598-018-34938-y
Narvi, Elli; Vaparanta, Katri; Karrila, Anna; Chakroborty, Deepankar; Knuutila, Sakari; Pulliainen, ...
Scientific reports2018Publicationer information ikon

Oxaliplatin Scale and National Cancer Institute-Common Toxicity Criteria in the Assessment of Chemotherapy-induced Peripheral Neuropathy

Referentgranskad
Kautio, Anna-Liisa; Haanpää, Maija Liisa; Kautiainen, Hannu; Leminen, Arto; Kalso, Eija; Saarto, Tii...
Anticancer research2011Publicationer information ikon

ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care

Referentgranskad
Iivanainen SME; Ravi R; Jekunen A; Arokoski R; Ekström J; Mentu S; Virtanen H; Kataja V; Koivunen JP
Annals of Oncology (dordrecht, Esmo)2021Publicationer information ikon

ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care

DOI
10.1016/j.annonc.2021.08.1667
Iivanainen, S.M.E.; Ravi, R.; Jekunen, A.; Arokoski, R.; Ekstrom, J.; Mentu, S.; Virtanen, H.; Kataj...
Annals of oncology2021Publicationer information ikon

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care:

Referentgranskad
Iivanainen S; Ravichandra R; Jekunen A; Arokoski R; Mentu S; Lang L; Ekström J; Virtanen H; Kataja V...
Journal of Cancer Research And Clinical Oncology2023Publicationer information ikon

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

Referentgranskad
Iivanainen S; Ravichandra R; Jekunen A; Arokoski R; Mentu S; Lang L; Ekström J; Virtanen H; Kataja V...
Journal of Cancer Research And Clinical Oncology2023Publicationer information ikon

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

Referentgranskad
Öppen tillgång
DOI
10.1007/s00432-023-04622-4
Iivanainen, Sanna; Ravichandra, Ravi; Jekunen, Antti; Arokoski, Reetta; Mentu, Santeri; Lang, Laura;...
Journal of cancer research and clinical oncology2023

Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer

Referentgranskad
Öppen tillgång
DOI
10.1016/j.ctarc.2022.100517
2022

Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy

Referentgranskad
DOI
10.1080/0284186X.2018.1556804
2019

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Referentgranskad
Öppen tillgång
2018

Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin

Referentgranskad
Öppen tillgång
DOI
10.1038/s41598-018-34938-y
2018

Oxaliplatin Scale and National Cancer Institute-Common Toxicity Criteria in the Assessment of Chemotherapy-induced Peripheral Neuropathy

Referentgranskad
2011

ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care

Referentgranskad
2021

ePRO follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care

DOI
10.1016/j.annonc.2021.08.1667
2021

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care:

Referentgranskad
2023

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

Referentgranskad
2023

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

Referentgranskad
Öppen tillgång
DOI
10.1007/s00432-023-04622-4
2023